224 results on '"Yudi, M."'
Search Results
2. Variances in Transcatheter Aortic Valve Implantation Uptake Across Australia: Insights From a Comparative Nationwide Study
3. Trends in Balloon Aortic Valvuloplasty Utilisation in the Transcatheter Aortic Valve Implantation Era: A Nationwide Study in Australia
4. Treatment of Mitral Regurgitation Using Surgical or Transcatheter Edge-to-Edge Repair: Early Trends in Australian Population-based Data
5. Transcatheter Aortic Valve Implantation in Australia: Early Trends in Low–Intermediate Surgical Risk Population ≤75 Years
6. Patent Foramen Ovale Closure Device Utilisation in Australia: National Trends and Impact of Landmark Trials on Procedural Volume Over 19 Years
7. Left Atrial Appendage Occlusion Utilisation for Atrial Fibrillation in Australia: A Nationwide Study
8. Multi-Disciplinary Team Derived Protocol to Facilitate Same Day Percutaneous Coronary Intervention–An Australian Experience
9. Abdominal Aortic Calcification Predicts Coronary Artery Calcium Score in Liver Transplant Patients
10. Abdominal Aortic Calcification Predicts Major Adverse Cardiovascular Outcomes After Liver Transplantation
11. Long-Term Outcomes in a Contemporary Population Being Managed Medically for Significant Left Main Stenosis
12. Impact of Clinical Presentation on Outcomes in Patients With Multivessel Coronary Artery Disease Managed Medically
13. Among Patients with Surgical Coronary Disease who do not Proceed onto Revascularisation, Cardiac Readmission Predicts Long Term Mortality
14. Among Patients with Surgical Coronary Artery Disease who do not Receive Revascularisation, Higher Antianginal Usage Predicts Long-Term Mortality
15. A Comparison of the TIMI-Risk Score and EuroSCORE in Prediction of Major Adverse Cardiovascular Events in Medically Managed Surgical Coronary Artery Disease
16. Cirrhotic Cardiomyopathy and Risk of Mortality in Patients Waitlisted for Liver Transplantation
17. Acute Aortic Regurgitation in a Bioprosthetic Aortic Valve
18. Impaired Cardiac Reserve is a Novel Predictor of Major Adverse Cardiovascular Events After Liver Transplantation
19. Radial Versus Femoral Access for Percutaneous Coronary Intervention in Patients With Stable Ischaemic Heart Disease
20. Long-term Survival after Percutaneous Coronary Intervention to Unprotected Left Main Coronary Artery (LMPCI) in the Absence of ST-Elevation MI (STEMI) or Cardiogenic Shock (CS)
21. Transcatheter Aortic Valve Implantation (TAVI) as a Bridge to Liver Transplantation: Experience From the Victorian Liver Transplant Unit
22. Natural History of Arterial Healing and Clinical Outcomes Following ST Elevation Myocardial Infarction Without Stent Insertion. Insights From the Victorian Cardiac Outcomes Registry (VCOR)
23. Feasibility of Selective Coronary Angiogram and Percutaneous Coronary Intervention Following Self-Expanding Transcatheter Aortic Valve Implantation – A Systematic Review and Meta-Analysis
24. Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era
25. Transcatheter Aortic Valve Replacement Versus Sutureless and Rapid Deployment Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis
26. SMARTphone-based Cardiovascular Risk Reduction in BREAST Cancer Patients [SMART-BREAST]: A Randomised Controlled Trial
27. Paradoxical Low Flow Low Gradient (LFLG) Severe Aortic Stenosis With Preserved Left Ventricular Ejection Fraction—An Under Recognised Entity
28. 863 Outcomes of Transcatheter Aortic Valve Replacement in Oncology Patients With Symptomatic Severe Aortic Stenosis
29. 864 Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients
30. 809 Comparison of Ischaemia-Guided Versus Angiography-Guided Revascularization in Stable Ischaemic Heart Disease
31. 795 Asymptomatic Patients Undergoing PCI for Stable Ischaemic Heart Disease Have Poorer Long-Term Survival Compared to Symptomatic Patients: Results From a Large Multi-Centre Australian Registry
32. 776 A History of Cancer Does Not Predict Long Term Mortality in Patients With Severe Aortic Stenosis
33. 734 Impact of Smoking Cessation on Long Term Mortality in Patients Undergoing Percutaneous Coronary Intervention
34. 533 Predictors of Medical Management in an Era of Transcatheter Aortic Valve Replacement
35. 475 Direct Oral Anticoagulant Therapy Versus Low-Molecular Weight Heparin for the Treatment of Venous Thrombo-Embolism Associated With Cancer
36. 473 Diabetes is an Independent Predictor of Sudden Cardiac Death Following Liver Transplantation: Results From the Australian And New Zealand Liver Transplant Registry Over 30 Years
37. 450 Balloon Aortic Valvuloplasty Alone Compared to Medical Therapy is Associated With Improved Long-Term Survival in Patients With Severe Aortic Stenosis
38. 183 The Role of Serum Cardiac Biomarkers and Left Ventricular Strain Imaging for Detecting Early Radiation Induced Myocardial Damage in Women Undergoing Left-Sided Breast Radiation Therapy
39. What is the Optimal Drug-Eluting Stent for Percutaneous Coronary Intervention in Patients with Insulin-Treated vs. Non-Insulin Treated Diabetes?
40. Safety and Long-Term Clinical Outcomes of Fractional Flow Reserve (FFR): An 8-year Study in a Real-world Setting
41. The Association Between Type II Myocardial Infarction and Increased In-Hospital Mortality in Patients aged >85 years with Non-ST-Elevation Myocardial Infarction
42. Management of NSTEMI in Elderly Patients: What do We Know About Conservative vs Invasive Management in the Elderly?
43. Predictors of Invasive Management in Patients Aged >85 Years with Non-ST-Elevation Myocardial Infarction (NSTEMI)
44. Long-term Outcomes of Percutaneous Coronary Intervention in Patients with Diabetes Mellitus: Results from a Large Multi-centre Australian Registry
45. Inpatient Coronary Angiography is Associated with Reduced Mortality in Patients aged >85 years with Non-ST-Elevation Myocardial Infarction
46. Impact of Gender and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting with ST-Elevation Myocardial Infarction (STEMI)
47. Coronary Angiography and Percutaneous Coronary Intervention Post Transcatheter Aortic Valve Implantation with Self-Expanding CoreValve
48. The Use of Secondary Preventative Smartphone Applications in Coronary Heart Disease (CHD): A Systematic Review and Meta-Analysis
49. Suboptimal Secondary Prevention Post Acute Coronary Syndromes: Insights from the SMART-REHAB Trial
50. Pre-Morbid Mobility Status and Long-Term Outcomes in Patients Aged >85 years with Non-ST-Elevation Myocardial Infarction (NSTEMI)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.